<DOC>
	<DOC>NCT01243983</DOC>
	<brief_summary>The primary objective of this study is to assess the safety and efficacy of voclosporin as therapy in subjects with active noninfectious uveitis involving the intermediate and/or posterior segments of the eye (i.e., anterior + intermediate-, intermediate-, posterior- or pan-uveitis).</brief_summary>
	<brief_title>Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis</brief_title>
	<detailed_description />
	<mesh_term>Uveitis</mesh_term>
	<criteria>Active noninfectious uveitis involving the intermediate and/or posterior segment (i.e., anterior + intermediate, intermediate, posterior or panuveitis) in at least one eye as evidenced by a vitreous haze grade of at least 2+ at the baseline visit. Subjects who also have anterior segment involvement need not be excluded if otherwise qualified. Subjects must be: Capable of understanding the purpose and risks of the study. Able to give written informed consent. Able to comply with all study requirements. Ocular Disease/Conditions The following conditions are exclusionary if present: Uveitis limited to only the anterior segment of the study eye. Confirmed or suspected infectious uveitis in either eye. Prior and Current Treatment: As defined in the protocol Extraocular Conditions: As defined in the protocol. Laboratory, Blood Pressure and ECG Evaluations: As defined in the protocol.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>